Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 USD | -4.14% | +4.52% | -24.48% |
May. 23 | Transcript : Trinity Biotech plc, Q1 2024 Earnings Call, May 23, 2024 | |
May. 23 | Trinity Biotech plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2022 | 74.78M | Sales 2023 | 56.83M | Capitalization | 16.39M |
---|---|---|---|---|---|
Net income 2022 | -41M | Net income 2023 | -24M | EV / Sales 2022 | 1.38 x |
Net Debt 2022 | 65.62M | Net Debt 2023 | 63.74M | EV / Sales 2023 | 1.41 x |
P/E ratio 2022 |
-0.81
x | P/E ratio 2023 |
-0.68
x | Employees | 380 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.35% |
Latest transcript on Trinity Biotech plc
1 day | +3.68% | ||
1 week | +6.96% | ||
Current month | -7.14% | ||
1 month | -7.65% | ||
3 months | -26.52% | ||
6 months | -9.99% | ||
Current year | -21.21% |
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 1.62 | -4.14% | 8 801 |
24-05-24 | 1.69 | +3.68% | 5,881 |
24-05-23 | 1.63 | +4.49% | 31,303 |
24-05-22 | 1.56 | +0.65% | 12,414 |
24-05-21 | 1.55 | -1.90% | 7,916 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.21% | 16M | |
-6.06% | 12.2B | |
-3.06% | 8.22B | |
+5.79% | 5.72B | |
+26.16% | 5.42B | |
-59.63% | 2.7B | |
+9.56% | 2.63B | |
-4.73% | 2.38B | |
+21.00% | 2.1B | |
-7.39% | 1.81B |
- Stock Market
- Equities
- TRIB Stock